CDC expands testing of international air traveler samples to include flu RSV, and other respiratory viruses

CDC
Nov 06, 2023

CDC expands testing of international air traveler samples to include flu RSV, and other respiratory viruses


CDC is conducting a new pilot on samples it is collecting as part of its Traveler-based Genomic Surveillance (TGS) program that will provide early detection of flu, RSV, and select other respiratory viruses, in addition to SARS-CoV-2.  The pilot, which will last for several months, will be implemented by Ginkgo Bioworks and XpresCheck. Samples that test positive for these viruses will be sequenced and uploaded to public databases to provide valuable information to public health officials and policy makers.

“The expansion of the Traveler-based Genomic Surveillance program to flu, RSV, and other pathogens is essential as we head into fall respiratory season. The TGS program, which began during the COVID-19 pandemic, acted as an early warning system to detect new and rare variants of the SARS-CoV-2 virus and will do the same for other respiratory viruses going forward,” said Dr. Cindy Friedman, chief of CDC’s Travelers’ Health Branch.